sur Medacta Group SA (isin : CH0468525222)
Medacta Group Announces Record 2025 Results and Positive Outlook
Medacta Group SA reported a significant financial year in 2025 with revenues reaching €683.8 million, reflecting an 18.5% increase in constant currency. This growth is attributed to the company's strategic innovations and global market expansions. Adjusted EBITDA rose 19.1% to €190.8 million, while net profit increased by 31% to €95.5 million.
The company also announced a proposed dividend increase of 59.4% to CHF 1.10 per share. The acquisition of Parcus Medical, a sports medicine specialist, contributed positively to the revenue. Medacta's geographic market expansion saw robust growth, particularly in Asia Pacific and North America.
Looking ahead, Medacta targets a 10-14% revenue increase in 2026. The company remains committed to sustainable innovation and enhancing its supply chain and production capabilities to meet future demands.
R. P.
Copyright © 2026 FinanzWire, tous droits de reproduction et de représentation réservés.
Clause de non responsabilité : bien que puisées aux meilleures sources, les informations et analyses diffusées par FinanzWire sont fournies à titre indicatif et ne constituent en aucune manière une incitation à prendre position sur les marchés financiers.
Cliquez ici pour consulter le communiqué de presse ayant servi de base à la rédaction de cette brève
Voir toutes les actualités de Medacta Group SA